| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Medication Adherence | 20 | 2022 | 267 | 4.650 |
Why?
|
| Diabetes Mellitus | 19 | 2020 | 530 | 3.450 |
Why?
|
| Hypoglycemic Agents | 12 | 2017 | 288 | 3.350 |
Why?
|
| Hypertension | 14 | 2023 | 524 | 3.170 |
Why?
|
| Humans | 173 | 2023 | 18430 | 3.150 |
Why?
|
| Male | 115 | 2023 | 10440 | 2.590 |
Why?
|
| Primary Health Care | 20 | 2020 | 848 | 2.470 |
Why?
|
| Female | 112 | 2023 | 13136 | 2.330 |
Why?
|
| Colorado | 42 | 2021 | 211 | 2.280 |
Why?
|
| Aged | 72 | 2023 | 6417 | 2.150 |
Why?
|
| Delivery of Health Care, Integrated | 13 | 2023 | 567 | 1.940 |
Why?
|
| Middle Aged | 73 | 2023 | 8284 | 1.910 |
Why?
|
| Ambulatory Care Facilities | 6 | 2021 | 77 | 1.820 |
Why?
|
| United States | 57 | 2022 | 4164 | 1.770 |
Why?
|
| Hispanic Americans | 10 | 2013 | 428 | 1.740 |
Why?
|
| Retrospective Studies | 36 | 2023 | 2550 | 1.720 |
Why?
|
| Antihypertensive Agents | 9 | 2023 | 172 | 1.720 |
Why?
|
| African Americans | 11 | 2021 | 490 | 1.710 |
Why?
|
| Adult | 60 | 2023 | 7910 | 1.660 |
Why?
|
| Delivery of Health Care | 11 | 2021 | 444 | 1.590 |
Why?
|
| Chronic Disease | 17 | 2019 | 468 | 1.490 |
Why?
|
| Appointments and Schedules | 5 | 2021 | 34 | 1.460 |
Why?
|
| Ambulatory Care | 7 | 2020 | 266 | 1.450 |
Why?
|
| Telephone | 5 | 2021 | 179 | 1.440 |
Why?
|
| Text Messaging | 2 | 2021 | 31 | 1.430 |
Why?
|
| Socioeconomic Factors | 22 | 2020 | 673 | 1.400 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2017 | 760 | 1.380 |
Why?
|
| Patient Acceptance of Health Care | 9 | 2022 | 407 | 1.330 |
Why?
|
| Mentors | 4 | 2015 | 12 | 1.270 |
Why?
|
| Blood Pressure | 10 | 2023 | 310 | 1.250 |
Why?
|
| Practice Patterns, Physicians' | 9 | 2019 | 350 | 1.250 |
Why?
|
| Electronic Health Records | 9 | 2020 | 747 | 1.240 |
Why?
|
| Cardiovascular Diseases | 9 | 2016 | 630 | 1.230 |
Why?
|
| Biomedical Research | 4 | 2014 | 93 | 1.190 |
Why?
|
| Patient-Centered Care | 7 | 2017 | 228 | 1.170 |
Why?
|
| Metformin | 3 | 2017 | 61 | 1.150 |
Why?
|
| Reminder Systems | 4 | 2021 | 94 | 1.140 |
Why?
|
| Patient Compliance | 7 | 2016 | 318 | 1.120 |
Why?
|
| Glycated Hemoglobin A | 9 | 2016 | 233 | 1.120 |
Why?
|
| Quality of Life | 8 | 2017 | 529 | 1.100 |
Why?
|
| Health Status | 9 | 2022 | 328 | 1.080 |
Why?
|
| Research | 6 | 2012 | 73 | 1.080 |
Why?
|
| Narration | 4 | 2016 | 11 | 1.050 |
Why?
|
| Comorbidity | 14 | 2015 | 619 | 1.050 |
Why?
|
| Neoplasms | 7 | 2014 | 457 | 1.040 |
Why?
|
| Cohort Studies | 27 | 2021 | 2672 | 1.030 |
Why?
|
| European Continental Ancestry Group | 6 | 2016 | 554 | 1.020 |
Why?
|
| Risk Factors | 26 | 2022 | 3449 | 1.010 |
Why?
|
| Health Maintenance Organizations | 9 | 2014 | 479 | 0.990 |
Why?
|
| Child Health Services | 8 | 2009 | 129 | 0.980 |
Why?
|
| Prostatic Neoplasms | 7 | 2014 | 298 | 0.970 |
Why?
|
| Comparative Effectiveness Research | 3 | 2015 | 77 | 0.970 |
Why?
|
| Translational Medical Research | 2 | 2015 | 39 | 0.950 |
Why?
|
| Adolescent | 24 | 2021 | 3798 | 0.910 |
Why?
|
| Health Services Needs and Demand | 6 | 2019 | 109 | 0.900 |
Why?
|
| Community-Institutional Relations | 3 | 2009 | 47 | 0.900 |
Why?
|
| Health Services Accessibility | 9 | 2021 | 320 | 0.890 |
Why?
|
| Hospitalization | 10 | 2022 | 847 | 0.890 |
Why?
|
| Survivors | 4 | 2010 | 158 | 0.890 |
Why?
|
| Prisoners | 4 | 2014 | 58 | 0.880 |
Why?
|
| Health Insurance Exchanges | 1 | 2022 | 5 | 0.860 |
Why?
|
| Health Services Research | 7 | 2019 | 264 | 0.850 |
Why?
|
| Loneliness | 1 | 2022 | 6 | 0.850 |
Why?
|
| Patient Participation | 2 | 2015 | 144 | 0.840 |
Why?
|
| Quality Assurance, Health Care | 6 | 2012 | 188 | 0.830 |
Why?
|
| Vulnerable Populations | 5 | 2009 | 47 | 0.820 |
Why?
|
| Immunization | 6 | 2009 | 80 | 0.810 |
Why?
|
| Hyperlipidemias | 3 | 2012 | 58 | 0.800 |
Why?
|
| Surveys and Questionnaires | 17 | 2022 | 1389 | 0.800 |
Why?
|
| Health Behavior | 8 | 2014 | 374 | 0.770 |
Why?
|
| Depression | 4 | 2022 | 518 | 0.770 |
Why?
|
| Sociological Factors | 1 | 2021 | 3 | 0.760 |
Why?
|
| Insulin | 3 | 2017 | 208 | 0.750 |
Why?
|
| Outcome Assessment (Health Care) | 5 | 2014 | 254 | 0.740 |
Why?
|
| State Health Plans | 4 | 2005 | 44 | 0.740 |
Why?
|
| Preventive Health Services | 4 | 2007 | 166 | 0.740 |
Why?
|
| Patient Satisfaction | 8 | 2013 | 232 | 0.740 |
Why?
|
| Needs Assessment | 2 | 2019 | 69 | 0.730 |
Why?
|
| Infant | 19 | 2022 | 1245 | 0.730 |
Why?
|
| Proportional Hazards Models | 8 | 2021 | 743 | 0.730 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 51 | 0.730 |
Why?
|
| Attitude of Health Personnel | 6 | 2012 | 226 | 0.720 |
Why?
|
| Hypokalemia | 1 | 2020 | 3 | 0.720 |
Why?
|
| Internal Medicine | 6 | 2008 | 27 | 0.720 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 5 | 2015 | 182 | 0.720 |
Why?
|
| Racism | 3 | 2021 | 22 | 0.710 |
Why?
|
| Anti-Infective Agents, Urinary | 1 | 2020 | 3 | 0.710 |
Why?
|
| Continuity of Patient Care | 4 | 2017 | 112 | 0.710 |
Why?
|
| Hyperkalemia | 1 | 2020 | 17 | 0.700 |
Why?
|
| Urinary Tract Infections | 1 | 2020 | 21 | 0.700 |
Why?
|
| Social Work | 1 | 2019 | 13 | 0.680 |
Why?
|
| Mass Screening | 6 | 2022 | 690 | 0.680 |
Why?
|
| Follow-Up Studies | 11 | 2022 | 1269 | 0.680 |
Why?
|
| Medical Order Entry Systems | 1 | 2019 | 15 | 0.680 |
Why?
|
| Young Adult | 17 | 2021 | 2518 | 0.670 |
Why?
|
| Urban Population | 6 | 2021 | 124 | 0.670 |
Why?
|
| Aged, 80 and over | 21 | 2021 | 2003 | 0.660 |
Why?
|
| Drug Prescriptions | 3 | 2009 | 157 | 0.660 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2019 | 56 | 0.660 |
Why?
|
| Research Personnel | 2 | 2016 | 30 | 0.650 |
Why?
|
| Time Factors | 13 | 2015 | 1136 | 0.650 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 105 | 0.640 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2008 | 15 | 0.630 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2017 | 124 | 0.630 |
Why?
|
| Cross-Sectional Studies | 18 | 2017 | 1360 | 0.630 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 142 | 0.620 |
Why?
|
| Physician-Patient Relations | 6 | 2013 | 197 | 0.620 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 208 | 0.610 |
Why?
|
| Self Administration | 2 | 2016 | 12 | 0.610 |
Why?
|
| Employment | 3 | 2008 | 48 | 0.610 |
Why?
|
| Prisons | 3 | 2014 | 32 | 0.610 |
Why?
|
| Risk Assessment | 9 | 2015 | 1143 | 0.600 |
Why?
|
| Health Services | 2 | 2012 | 117 | 0.600 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 259 | 0.590 |
Why?
|
| Age Factors | 11 | 2020 | 965 | 0.580 |
Why?
|
| Office Visits | 4 | 2007 | 86 | 0.580 |
Why?
|
| Heart Failure | 7 | 2015 | 398 | 0.580 |
Why?
|
| Models, Biological | 1 | 2017 | 32 | 0.580 |
Why?
|
| Internet | 6 | 2016 | 243 | 0.570 |
Why?
|
| Food Supply | 1 | 2017 | 36 | 0.570 |
Why?
|
| Computer Communication Networks | 2 | 2014 | 18 | 0.570 |
Why?
|
| Attitude to Health | 4 | 2021 | 177 | 0.570 |
Why?
|
| Clinical Competence | 4 | 2014 | 108 | 0.570 |
Why?
|
| Cooperative Behavior | 2 | 2014 | 102 | 0.570 |
Why?
|
| Registries | 10 | 2015 | 490 | 0.560 |
Why?
|
| Family Practice | 5 | 2008 | 53 | 0.560 |
Why?
|
| Cholesterol, LDL | 6 | 2016 | 125 | 0.550 |
Why?
|
| Referral and Consultation | 3 | 2014 | 180 | 0.540 |
Why?
|
| Games, Recreational | 1 | 2016 | 1 | 0.540 |
Why?
|
| Child, Preschool | 15 | 2020 | 1478 | 0.540 |
Why?
|
| Insurance, Health | 6 | 2022 | 217 | 0.540 |
Why?
|
| Self Report | 4 | 2022 | 256 | 0.540 |
Why?
|
| Problem Solving | 1 | 2016 | 11 | 0.540 |
Why?
|
| Medically Uninsured | 4 | 2007 | 61 | 0.510 |
Why?
|
| Competency-Based Education | 1 | 2015 | 3 | 0.500 |
Why?
|
| Professional Competence | 1 | 2015 | 12 | 0.500 |
Why?
|
| Sickness Impact Profile | 2 | 2005 | 28 | 0.500 |
Why?
|
| Practice Guidelines as Topic | 4 | 2014 | 333 | 0.500 |
Why?
|
| Faculty, Medical | 2 | 2014 | 10 | 0.490 |
Why?
|
| Kidney Failure, Chronic | 3 | 2021 | 151 | 0.490 |
Why?
|
| Monitoring, Physiologic | 1 | 2014 | 41 | 0.480 |
Why?
|
| Health Care Surveys | 9 | 2013 | 247 | 0.480 |
Why?
|
| Blood Glucose | 4 | 2015 | 346 | 0.480 |
Why?
|
| Healthcare Disparities | 6 | 2022 | 211 | 0.480 |
Why?
|
| Counseling | 2 | 2014 | 197 | 0.470 |
Why?
|
| Databases as Topic | 1 | 2014 | 22 | 0.470 |
Why?
|
| Kidney Diseases | 2 | 2011 | 55 | 0.470 |
Why?
|
| Prescription Drugs | 1 | 2014 | 33 | 0.460 |
Why?
|
| Community Health Centers | 3 | 2012 | 112 | 0.460 |
Why?
|
| Renal Dialysis | 4 | 2023 | 59 | 0.460 |
Why?
|
| Terminology as Topic | 1 | 2013 | 21 | 0.450 |
Why?
|
| Medical Assistance | 2 | 2022 | 10 | 0.450 |
Why?
|
| Self Care | 5 | 2008 | 175 | 0.450 |
Why?
|
| Quality of Health Care | 7 | 2021 | 347 | 0.450 |
Why?
|
| Health Status Disparities | 4 | 2022 | 153 | 0.440 |
Why?
|
| Emergency Service, Hospital | 2 | 2015 | 382 | 0.440 |
Why?
|
| Overweight | 2 | 2022 | 276 | 0.440 |
Why?
|
| Fellowships and Scholarships | 3 | 2003 | 14 | 0.440 |
Why?
|
| Child | 13 | 2020 | 2571 | 0.430 |
Why?
|
| Morbidity | 2 | 2015 | 62 | 0.430 |
Why?
|
| Treatment Refusal | 3 | 2007 | 38 | 0.430 |
Why?
|
| Social Support | 4 | 2019 | 214 | 0.420 |
Why?
|
| International Classification of Diseases | 2 | 2015 | 87 | 0.420 |
Why?
|
| Medicare Part C | 1 | 2012 | 22 | 0.420 |
Why?
|
| Anticholesteremic Agents | 1 | 2012 | 15 | 0.420 |
Why?
|
| Osteoarthritis | 3 | 2008 | 23 | 0.410 |
Why?
|
| Workplace | 2 | 2010 | 36 | 0.410 |
Why?
|
| Vaccination | 3 | 2022 | 674 | 0.410 |
Why?
|
| Prostatectomy | 3 | 2006 | 79 | 0.410 |
Why?
|
| Life Style | 1 | 2014 | 342 | 0.400 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2012 | 126 | 0.400 |
Why?
|
| Undocumented Immigrants | 2 | 2023 | 2 | 0.400 |
Why?
|
| Hypoglycemia | 3 | 2017 | 49 | 0.400 |
Why?
|
| Odds Ratio | 6 | 2021 | 701 | 0.400 |
Why?
|
| Outcome and Process Assessment (Health Care) | 1 | 2012 | 110 | 0.400 |
Why?
|
| Pharmaceutical Services | 2 | 2013 | 37 | 0.400 |
Why?
|
| Social Adjustment | 1 | 2011 | 16 | 0.390 |
Why?
|
| Pneumococcal Vaccines | 3 | 2008 | 80 | 0.390 |
Why?
|
| Hypolipidemic Agents | 1 | 2011 | 44 | 0.390 |
Why?
|
| Electrocardiography | 2 | 2008 | 44 | 0.390 |
Why?
|
| Case Management | 2 | 2009 | 37 | 0.390 |
Why?
|
| Health Education | 2 | 2011 | 115 | 0.390 |
Why?
|
| Health Surveys | 6 | 2015 | 269 | 0.380 |
Why?
|
| Anxiety | 3 | 2022 | 156 | 0.380 |
Why?
|
| Multivariate Analysis | 11 | 2014 | 598 | 0.380 |
Why?
|
| Minority Groups | 3 | 2022 | 105 | 0.380 |
Why?
|
| Drug Overdose | 1 | 2012 | 57 | 0.380 |
Why?
|
| Qualitative Research | 6 | 2021 | 272 | 0.380 |
Why?
|
| Interprofessional Relations | 3 | 2014 | 25 | 0.370 |
Why?
|
| Managed Care Programs | 6 | 2017 | 347 | 0.370 |
Why?
|
| Severity of Illness Index | 5 | 2017 | 476 | 0.360 |
Why?
|
| Health Policy | 3 | 2007 | 136 | 0.360 |
Why?
|
| Survival Analysis | 2 | 2008 | 226 | 0.360 |
Why?
|
| Models, Statistical | 3 | 2014 | 185 | 0.360 |
Why?
|
| Infant, Newborn | 7 | 2009 | 872 | 0.360 |
Why?
|
| Immunization Programs | 4 | 2007 | 68 | 0.350 |
Why?
|
| Depressive Disorder | 2 | 2011 | 231 | 0.350 |
Why?
|
| Internship and Residency | 4 | 2006 | 50 | 0.350 |
Why?
|
| Health Status Indicators | 2 | 2014 | 71 | 0.340 |
Why?
|
| Bell Palsy | 1 | 2009 | 17 | 0.340 |
Why?
|
| Urban Health | 2 | 2006 | 40 | 0.340 |
Why?
|
| Insurance Coverage | 3 | 2007 | 136 | 0.340 |
Why?
|
| Hydralazine | 1 | 2009 | 1 | 0.330 |
Why?
|
| Isosorbide Dinitrate | 1 | 2009 | 1 | 0.330 |
Why?
|
| Vasodilator Agents | 1 | 2009 | 10 | 0.330 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2009 | 72 | 0.330 |
Why?
|
| Triage | 2 | 2006 | 17 | 0.330 |
Why?
|
| Absorptiometry, Photon | 1 | 2009 | 52 | 0.330 |
Why?
|
| Antiviral Agents | 1 | 2009 | 95 | 0.320 |
Why?
|
| Information Dissemination | 2 | 2016 | 57 | 0.320 |
Why?
|
| African Continental Ancestry Group | 1 | 2009 | 166 | 0.320 |
Why?
|
| Health Promotion | 2 | 2009 | 294 | 0.320 |
Why?
|
| Bone Density | 1 | 2009 | 96 | 0.320 |
Why?
|
| Population Surveillance | 4 | 2019 | 271 | 0.320 |
Why?
|
| Linear Models | 5 | 2011 | 243 | 0.310 |
Why?
|
| Social Values | 2 | 2021 | 16 | 0.310 |
Why?
|
| Physician Impairment | 1 | 2007 | 1 | 0.300 |
Why?
|
| Substance-Related Disorders | 2 | 2012 | 439 | 0.300 |
Why?
|
| Incidence | 7 | 2015 | 1314 | 0.300 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2007 | 27 | 0.300 |
Why?
|
| Community Health Services | 2 | 2008 | 86 | 0.290 |
Why?
|
| Prognosis | 5 | 2017 | 624 | 0.290 |
Why?
|
| Hospitals, University | 2 | 2008 | 20 | 0.290 |
Why?
|
| Child Care | 1 | 2007 | 12 | 0.290 |
Why?
|
| Urology | 1 | 2006 | 6 | 0.290 |
Why?
|
| Dyslipidemias | 1 | 2007 | 65 | 0.280 |
Why?
|
| Postoperative Complications | 2 | 2007 | 103 | 0.280 |
Why?
|
| Policy Making | 2 | 2005 | 18 | 0.280 |
Why?
|
| After-Hours Care | 1 | 2006 | 3 | 0.280 |
Why?
|
| Emergencies | 1 | 2006 | 6 | 0.280 |
Why?
|
| Prevalence | 8 | 2019 | 911 | 0.280 |
Why?
|
| Data Collection | 6 | 2012 | 275 | 0.270 |
Why?
|
| Carcinoma | 1 | 2006 | 27 | 0.270 |
Why?
|
| Interviews as Topic | 6 | 2011 | 327 | 0.270 |
Why?
|
| Wounds and Injuries | 2 | 2006 | 51 | 0.270 |
Why?
|
| Clinical Medicine | 1 | 2005 | 5 | 0.270 |
Why?
|
| Hospitals, Pediatric | 1 | 2006 | 80 | 0.260 |
Why?
|
| Marital Status | 1 | 2005 | 22 | 0.250 |
Why?
|
| Value of Life | 1 | 2005 | 7 | 0.250 |
Why?
|
| Disease Management | 4 | 2015 | 143 | 0.250 |
Why?
|
| Work | 1 | 2004 | 12 | 0.250 |
Why?
|
| Diabetes, Gestational | 2 | 2022 | 339 | 0.240 |
Why?
|
| Colorectal Neoplasms | 4 | 2014 | 656 | 0.240 |
Why?
|
| Patient Education as Topic | 3 | 2014 | 214 | 0.240 |
Why?
|
| Foot Deformities | 1 | 2004 | 1 | 0.240 |
Why?
|
| Foot Diseases | 1 | 2004 | 2 | 0.240 |
Why?
|
| Physician's Role | 1 | 2004 | 32 | 0.240 |
Why?
|
| Medicare | 3 | 2015 | 214 | 0.240 |
Why?
|
| Prospective Studies | 5 | 2023 | 1314 | 0.230 |
Why?
|
| Kidney | 3 | 2022 | 54 | 0.230 |
Why?
|
| Program Evaluation | 4 | 2014 | 244 | 0.230 |
Why?
|
| Insurance Claim Review | 3 | 2015 | 70 | 0.230 |
Why?
|
| Child, Hospitalized | 1 | 2003 | 15 | 0.230 |
Why?
|
| Renal Insufficiency | 1 | 2023 | 13 | 0.220 |
Why?
|
| Chi-Square Distribution | 3 | 2012 | 160 | 0.220 |
Why?
|
| Computer Security | 2 | 2014 | 8 | 0.220 |
Why?
|
| Medical Staff | 1 | 2002 | 2 | 0.220 |
Why?
|
| Smoking | 3 | 2015 | 494 | 0.220 |
Why?
|
| Confidentiality | 2 | 2014 | 30 | 0.210 |
Why?
|
| Health Facilities | 1 | 2022 | 18 | 0.210 |
Why?
|
| Behavior Therapy | 1 | 2004 | 155 | 0.210 |
Why?
|
| Demography | 4 | 2008 | 108 | 0.210 |
Why?
|
| Training Support | 1 | 2002 | 1 | 0.210 |
Why?
|
| Phobic Disorders | 1 | 2022 | 1 | 0.210 |
Why?
|
| Poverty | 4 | 2004 | 182 | 0.210 |
Why?
|
| Medical Records Systems, Computerized | 3 | 2008 | 95 | 0.210 |
Why?
|
| Quality Improvement | 2 | 2015 | 207 | 0.210 |
Why?
|
| Awards and Prizes | 1 | 2002 | 10 | 0.210 |
Why?
|
| Health Knowledge, Attitudes, Practice | 6 | 2021 | 392 | 0.200 |
Why?
|
| Regression Analysis | 5 | 2007 | 319 | 0.200 |
Why?
|
| Health Fairs | 1 | 2002 | 2 | 0.200 |
Why?
|
| Mental Disorders | 2 | 2008 | 295 | 0.200 |
Why?
|
| Critical Care | 1 | 2022 | 73 | 0.200 |
Why?
|
| Anxiety Disorders | 1 | 2022 | 93 | 0.200 |
Why?
|
| Drug Therapy, Combination | 2 | 2014 | 119 | 0.200 |
Why?
|
| Culturally Competent Care | 1 | 2021 | 12 | 0.200 |
Why?
|
| Acculturation | 2 | 2012 | 22 | 0.200 |
Why?
|
| Complementary Therapies | 1 | 2002 | 50 | 0.190 |
Why?
|
| Patient Selection | 3 | 2009 | 198 | 0.190 |
Why?
|
| Communication Barriers | 1 | 2021 | 32 | 0.190 |
Why?
|
| New Mexico | 1 | 2021 | 7 | 0.190 |
Why?
|
| Exercise | 3 | 2021 | 495 | 0.190 |
Why?
|
| Geography | 1 | 2020 | 41 | 0.180 |
Why?
|
| Pandemics | 1 | 2023 | 292 | 0.180 |
Why?
|
| Colonoscopy | 3 | 2008 | 268 | 0.180 |
Why?
|
| Logistic Models | 4 | 2012 | 962 | 0.180 |
Why?
|
| Treatment Outcome | 5 | 2012 | 1296 | 0.180 |
Why?
|
| Public Health Surveillance | 1 | 2020 | 45 | 0.180 |
Why?
|
| Cephalexin | 1 | 2020 | 2 | 0.180 |
Why?
|
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2020 | 3 | 0.180 |
Why?
|
| Cystitis | 1 | 2020 | 3 | 0.180 |
Why?
|
| Potassium | 1 | 2020 | 17 | 0.180 |
Why?
|
| Pyelonephritis | 1 | 2020 | 4 | 0.180 |
Why?
|
| Transportation | 1 | 2020 | 13 | 0.180 |
Why?
|
| Disease Progression | 2 | 2011 | 271 | 0.180 |
Why?
|
| Neoplasm Staging | 1 | 2021 | 337 | 0.180 |
Why?
|
| Interrupted Time Series Analysis | 1 | 2020 | 24 | 0.180 |
Why?
|
| Electronic Mail | 2 | 2013 | 53 | 0.170 |
Why?
|
| HIV Infections | 3 | 2011 | 695 | 0.170 |
Why?
|
| Information Services | 1 | 2019 | 18 | 0.170 |
Why?
|
| Secondary Prevention | 2 | 2017 | 52 | 0.170 |
Why?
|
| Patient Navigation | 1 | 2019 | 17 | 0.170 |
Why?
|
| Communication | 3 | 2012 | 202 | 0.170 |
Why?
|
| Ethnic Groups | 2 | 2014 | 501 | 0.170 |
Why?
|
| Cluster Analysis | 3 | 2011 | 96 | 0.170 |
Why?
|
| Decision Making | 3 | 2006 | 204 | 0.170 |
Why?
|
| Survival Rate | 4 | 2015 | 269 | 0.160 |
Why?
|
| Predictive Value of Tests | 3 | 2010 | 365 | 0.160 |
Why?
|
| Patients | 2 | 2011 | 38 | 0.160 |
Why?
|
| Anti-HIV Agents | 2 | 2011 | 154 | 0.160 |
Why?
|
| Parents | 3 | 2006 | 309 | 0.160 |
Why?
|
| Pediatrics | 3 | 2006 | 166 | 0.160 |
Why?
|
| Pregnancy | 3 | 2022 | 1516 | 0.160 |
Why?
|
| Probability | 3 | 2010 | 86 | 0.150 |
Why?
|
| Nomograms | 2 | 2014 | 13 | 0.150 |
Why?
|
| Physicians, Family | 2 | 2008 | 47 | 0.150 |
Why?
|
| Minnesota | 1 | 2017 | 54 | 0.150 |
Why?
|
| Epidemiological Monitoring | 2 | 2015 | 27 | 0.150 |
Why?
|
| Blood Pressure Determination | 2 | 2015 | 58 | 0.140 |
Why?
|
| Northwestern United States | 1 | 2017 | 58 | 0.140 |
Why?
|
| Glomerular Filtration Rate | 3 | 2015 | 157 | 0.140 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2017 | 54 | 0.140 |
Why?
|
| Cost of Illness | 2 | 2008 | 100 | 0.140 |
Why?
|
| House Calls | 2 | 2009 | 13 | 0.140 |
Why?
|
| Utilization Review | 2 | 2009 | 56 | 0.140 |
Why?
|
| Information Seeking Behavior | 1 | 2016 | 11 | 0.130 |
Why?
|
| Pulmonary Fibrosis | 1 | 2016 | 10 | 0.130 |
Why?
|
| Models, Theoretical | 1 | 2016 | 76 | 0.130 |
Why?
|
| Social Media | 1 | 2016 | 12 | 0.130 |
Why?
|
| Physicians | 2 | 2008 | 141 | 0.130 |
Why?
|
| Residence Characteristics | 1 | 2017 | 256 | 0.130 |
Why?
|
| Blood Chemical Analysis | 1 | 2014 | 5 | 0.120 |
Why?
|
| Diabetic Nephropathies | 1 | 2015 | 28 | 0.120 |
Why?
|
| Diabetic Angiopathies | 1 | 2015 | 36 | 0.120 |
Why?
|
| Total Quality Management | 2 | 2007 | 27 | 0.120 |
Why?
|
| Arizona | 1 | 2014 | 6 | 0.120 |
Why?
|
| SEER Program | 3 | 2014 | 101 | 0.120 |
Why?
|
| Medicaid | 2 | 2009 | 211 | 0.120 |
Why?
|
| Nurses | 2 | 2006 | 40 | 0.120 |
Why?
|
| Organizational Policy | 1 | 2014 | 17 | 0.120 |
Why?
|
| Pharmacists | 1 | 2014 | 48 | 0.120 |
Why?
|
| Teaching | 2 | 2006 | 16 | 0.120 |
Why?
|
| Influenza Vaccines | 2 | 2008 | 290 | 0.120 |
Why?
|
| Privacy | 1 | 2014 | 7 | 0.120 |
Why?
|
| Cost Sharing | 2 | 2015 | 40 | 0.120 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 31 | 0.120 |
Why?
|
| Continental Population Groups | 2 | 2014 | 315 | 0.120 |
Why?
|
| Curriculum | 1 | 2014 | 40 | 0.120 |
Why?
|
| Program Development | 2 | 2019 | 81 | 0.120 |
Why?
|
| User-Computer Interface | 2 | 2012 | 28 | 0.110 |
Why?
|
| Eligibility Determination | 2 | 2004 | 17 | 0.110 |
Why?
|
| Sex Characteristics | 1 | 2014 | 70 | 0.110 |
Why?
|
| Sulfonylurea Compounds | 1 | 2013 | 28 | 0.110 |
Why?
|
| Natural Language Processing | 1 | 2014 | 57 | 0.110 |
Why?
|
| Antiretroviral Therapy, Highly Active | 2 | 2011 | 95 | 0.110 |
Why?
|
| Multicenter Studies as Topic | 1 | 2013 | 91 | 0.110 |
Why?
|
| Remote Consultation | 1 | 2013 | 11 | 0.110 |
Why?
|
| Patient Access to Records | 1 | 2013 | 18 | 0.110 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2015 | 180 | 0.110 |
Why?
|
| Stereotyped Behavior | 1 | 2012 | 2 | 0.110 |
Why?
|
| Obesity | 2 | 2022 | 855 | 0.110 |
Why?
|
| Family | 2 | 2012 | 120 | 0.110 |
Why?
|
| Reimbursement, Incentive | 1 | 2012 | 31 | 0.110 |
Why?
|
| Cultural Competency | 2 | 2013 | 14 | 0.100 |
Why?
|
| Medical Record Linkage | 1 | 2012 | 44 | 0.100 |
Why?
|
| Medical Informatics | 1 | 2012 | 45 | 0.100 |
Why?
|
| Physicians, Primary Care | 1 | 2013 | 74 | 0.100 |
Why?
|
| Databases, Factual | 1 | 2013 | 327 | 0.100 |
Why?
|
| Urban Health Services | 2 | 2009 | 13 | 0.100 |
Why?
|
| Forensic Psychiatry | 1 | 2011 | 2 | 0.100 |
Why?
|
| Clinical Trials as Topic | 2 | 2019 | 133 | 0.100 |
Why?
|
| Primary Prevention | 2 | 2013 | 79 | 0.100 |
Why?
|
| Biomarkers | 1 | 2012 | 308 | 0.100 |
Why?
|
| Mental Health Services | 2 | 2004 | 161 | 0.100 |
Why?
|
| Sex Factors | 4 | 2020 | 661 | 0.090 |
Why?
|
| Risk-Taking | 1 | 2011 | 109 | 0.090 |
Why?
|
| Longitudinal Studies | 3 | 2013 | 724 | 0.090 |
Why?
|
| Mental Health | 1 | 2012 | 168 | 0.090 |
Why?
|
| Algorithms | 2 | 2011 | 241 | 0.090 |
Why?
|
| Suicide | 1 | 2012 | 126 | 0.090 |
Why?
|
| Audiovisual Aids | 1 | 2009 | 4 | 0.090 |
Why?
|
| Computer-Assisted Instruction | 1 | 2009 | 11 | 0.090 |
Why?
|
| Medicare Part D | 1 | 2010 | 21 | 0.090 |
Why?
|
| Patient Readmission | 1 | 2012 | 162 | 0.090 |
Why?
|
| Safety | 2 | 2007 | 45 | 0.090 |
Why?
|
| Adaptation, Psychological | 1 | 2010 | 82 | 0.090 |
Why?
|
| Drug Resistance, Viral | 1 | 2009 | 13 | 0.080 |
Why?
|
| HIV-1 | 1 | 2009 | 71 | 0.080 |
Why?
|
| Drug Combinations | 1 | 2009 | 43 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2008 | 342 | 0.080 |
Why?
|
| Self Disclosure | 1 | 2008 | 24 | 0.080 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2011 | 199 | 0.080 |
Why?
|
| Nutrition Surveys | 1 | 2008 | 63 | 0.080 |
Why?
|
| Geriatrics | 1 | 2008 | 8 | 0.080 |
Why?
|
| Attitude | 2 | 2005 | 33 | 0.080 |
Why?
|
| Health Services for the Aged | 1 | 2008 | 15 | 0.080 |
Why?
|
| Medically Underserved Area | 1 | 2008 | 17 | 0.080 |
Why?
|
| Activities of Daily Living | 2 | 2008 | 96 | 0.080 |
Why?
|
| Osteoporosis | 1 | 2009 | 76 | 0.080 |
Why?
|
| Psychology | 1 | 2008 | 17 | 0.080 |
Why?
|
| Organizational Case Studies | 1 | 2008 | 25 | 0.080 |
Why?
|
| Sentinel Surveillance | 1 | 2008 | 14 | 0.080 |
Why?
|
| Neuralgia, Postherpetic | 1 | 2008 | 15 | 0.080 |
Why?
|
| Alcoholism | 1 | 2012 | 350 | 0.080 |
Why?
|
| Statistics as Topic | 1 | 2008 | 66 | 0.080 |
Why?
|
| Culture | 1 | 2007 | 29 | 0.070 |
Why?
|
| Asthma | 1 | 2011 | 390 | 0.070 |
Why?
|
| Veterans | 1 | 2009 | 138 | 0.070 |
Why?
|
| Cholesterol | 1 | 2007 | 112 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2007 | 167 | 0.070 |
Why?
|
| Surgical Procedures, Operative | 1 | 2007 | 17 | 0.070 |
Why?
|
| Correspondence as Topic | 1 | 2007 | 5 | 0.070 |
Why?
|
| Sex Distribution | 1 | 2007 | 198 | 0.070 |
Why?
|
| Pamphlets | 1 | 2006 | 8 | 0.070 |
Why?
|
| Herpes Zoster Vaccine | 1 | 2008 | 64 | 0.070 |
Why?
|
| Accident Prevention | 1 | 2006 | 3 | 0.070 |
Why?
|
| Erectile Dysfunction | 1 | 2006 | 25 | 0.070 |
Why?
|
| Models, Organizational | 1 | 2007 | 65 | 0.070 |
Why?
|
| Anecdotes as Topic | 1 | 2006 | 1 | 0.070 |
Why?
|
| Urinary Incontinence | 1 | 2006 | 33 | 0.070 |
Why?
|
| Diagnosis-Related Groups | 1 | 2006 | 27 | 0.070 |
Why?
|
| Herpes Zoster | 1 | 2008 | 88 | 0.070 |
Why?
|
| Medical Staff, Hospital | 1 | 2006 | 8 | 0.070 |
Why?
|
| Patient Dropouts | 1 | 2006 | 23 | 0.070 |
Why?
|
| Educational Status | 1 | 2006 | 205 | 0.070 |
Why?
|
| Mortality | 1 | 2006 | 123 | 0.070 |
Why?
|
| Drug Costs | 1 | 2005 | 40 | 0.060 |
Why?
|
| Goals | 1 | 2005 | 33 | 0.060 |
Why?
|
| Hospital Costs | 1 | 2005 | 41 | 0.060 |
Why?
|
| Brachytherapy | 1 | 2005 | 6 | 0.060 |
Why?
|
| Self Concept | 1 | 2005 | 42 | 0.060 |
Why?
|
| United Kingdom | 1 | 2005 | 32 | 0.060 |
Why?
|
| Social Class | 1 | 2005 | 125 | 0.060 |
Why?
|
| Stress, Psychological | 1 | 2006 | 147 | 0.060 |
Why?
|
| Risk | 1 | 2006 | 552 | 0.060 |
Why?
|
| Postal Service | 3 | 2015 | 83 | 0.060 |
Why?
|
| Chicago | 1 | 2004 | 27 | 0.060 |
Why?
|
| Boston | 1 | 2004 | 37 | 0.060 |
Why?
|
| Fee-for-Service Plans | 1 | 2004 | 28 | 0.060 |
Why?
|
| Specialization | 1 | 2004 | 26 | 0.060 |
Why?
|
| Medicine | 1 | 2004 | 23 | 0.060 |
Why?
|
| Age Distribution | 1 | 2005 | 261 | 0.060 |
Why?
|
| National Center for Health Statistics (U.S.) | 1 | 2004 | 1 | 0.060 |
Why?
|
| Podiatry | 1 | 2004 | 3 | 0.060 |
Why?
|
| Public Health Practice | 1 | 2004 | 14 | 0.060 |
Why?
|
| Schools, Medical | 1 | 2004 | 17 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2006 | 249 | 0.060 |
Why?
|
| Happiness | 1 | 2004 | 2 | 0.060 |
Why?
|
| Los Angeles | 1 | 2004 | 141 | 0.060 |
Why?
|
| Psychometrics | 1 | 2004 | 124 | 0.060 |
Why?
|
| Hospitals, Urban | 1 | 2003 | 13 | 0.060 |
Why?
|
| Medical Indigency | 1 | 2003 | 5 | 0.060 |
Why?
|
| Echinacea | 1 | 2003 | 1 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2005 | 195 | 0.060 |
Why?
|
| Public Health Informatics | 1 | 2003 | 8 | 0.060 |
Why?
|
| Drug Labeling | 1 | 2003 | 15 | 0.050 |
Why?
|
| Self-Help Groups | 1 | 2023 | 32 | 0.050 |
Why?
|
| Truth Disclosure | 1 | 2003 | 17 | 0.050 |
Why?
|
| Professional Autonomy | 1 | 2002 | 1 | 0.050 |
Why?
|
| Emergency Medicine | 1 | 2002 | 6 | 0.050 |
Why?
|
| Herpesvirus 2, Human | 1 | 2002 | 4 | 0.050 |
Why?
|
| Herpes Genitalis | 1 | 2002 | 4 | 0.050 |
Why?
|
| Publishing | 1 | 2002 | 9 | 0.050 |
Why?
|
| Fetal Macrosomia | 1 | 2022 | 27 | 0.050 |
Why?
|
| Home Care Agencies | 1 | 2002 | 3 | 0.050 |
Why?
|
| Emergency Medical Services | 1 | 2002 | 47 | 0.050 |
Why?
|
| Ventricular Function, Left | 1 | 2003 | 50 | 0.050 |
Why?
|
| Cause of Death | 2 | 2015 | 185 | 0.050 |
Why?
|
| Hotlines | 1 | 2002 | 16 | 0.050 |
Why?
|
| ROC Curve | 2 | 2014 | 83 | 0.050 |
Why?
|
| Home Care Services | 1 | 2002 | 23 | 0.050 |
Why?
|
| Athletic Injuries | 1 | 2002 | 4 | 0.050 |
Why?
|
| Financing, Personal | 1 | 2002 | 24 | 0.050 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2002 | 55 | 0.050 |
Why?
|
| Drug Utilization | 2 | 2015 | 134 | 0.050 |
Why?
|
| Research Design | 1 | 2004 | 402 | 0.050 |
Why?
|
| Writing | 1 | 2021 | 12 | 0.050 |
Why?
|
| Intention to Treat Analysis | 1 | 2021 | 23 | 0.050 |
Why?
|
| Outpatients | 1 | 2002 | 111 | 0.050 |
Why?
|
| Single-Blind Method | 1 | 2021 | 47 | 0.050 |
Why?
|
| Likelihood Functions | 1 | 2002 | 48 | 0.050 |
Why?
|
| Developmental Disabilities | 1 | 2002 | 53 | 0.050 |
Why?
|
| Professional-Patient Relations | 1 | 2021 | 48 | 0.050 |
Why?
|
| Social Stigma | 1 | 2021 | 19 | 0.050 |
Why?
|
| Dietary Fats | 1 | 2002 | 92 | 0.050 |
Why?
|
| Social Isolation | 1 | 2021 | 16 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2014 | 237 | 0.050 |
Why?
|
| Health Literacy | 1 | 2021 | 40 | 0.050 |
Why?
|
| Weight Gain | 1 | 2022 | 181 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2003 | 1173 | 0.050 |
Why?
|
| Quality Indicators, Health Care | 2 | 2014 | 197 | 0.040 |
Why?
|
| Caregivers | 1 | 2020 | 126 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2022 | 974 | 0.040 |
Why?
|
| Multilevel Analysis | 1 | 2017 | 13 | 0.040 |
Why?
|
| Censuses | 1 | 2017 | 32 | 0.040 |
Why?
|
| Confidence Intervals | 2 | 2012 | 253 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 150 | 0.030 |
Why?
|
| Information Storage and Retrieval | 1 | 2015 | 16 | 0.030 |
Why?
|
| Albuminuria | 1 | 2015 | 41 | 0.030 |
Why?
|
| State Government | 1 | 2014 | 14 | 0.030 |
Why?
|
| Poisson Distribution | 1 | 2014 | 94 | 0.030 |
Why?
|
| Smoking Prevention | 1 | 2014 | 55 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2005 | 399 | 0.030 |
Why?
|
| Terminally Ill | 1 | 2013 | 9 | 0.030 |
Why?
|
| Affect | 1 | 2012 | 26 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2015 | 249 | 0.030 |
Why?
|
| Trust | 1 | 2012 | 31 | 0.030 |
Why?
|
| Age of Onset | 1 | 2012 | 82 | 0.030 |
Why?
|
| Stroke | 1 | 2015 | 311 | 0.030 |
Why?
|
| Data Mining | 1 | 2011 | 20 | 0.020 |
Why?
|
| Multilingualism | 1 | 2009 | 8 | 0.020 |
Why?
|
| Vascular Diseases | 1 | 2009 | 5 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 131 | 0.020 |
Why?
|
| Mexican Americans | 1 | 2010 | 48 | 0.020 |
Why?
|
| Community-Based Participatory Research | 1 | 2009 | 63 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2009 | 119 | 0.020 |
Why?
|
| Genotype | 1 | 2009 | 253 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2009 | 168 | 0.020 |
Why?
|
| Observation | 1 | 2008 | 25 | 0.020 |
Why?
|
| Health Care Rationing | 1 | 2007 | 14 | 0.020 |
Why?
|
| Epidemiologic Research Design | 1 | 2008 | 24 | 0.020 |
Why?
|
| Herpesvirus 3, Human | 1 | 2008 | 49 | 0.020 |
Why?
|
| Personnel Turnover | 1 | 2007 | 5 | 0.020 |
Why?
|
| Private Sector | 1 | 2007 | 16 | 0.020 |
Why?
|
| Hospitals, Veterans | 1 | 2007 | 34 | 0.020 |
Why?
|
| Domestic Violence | 1 | 2006 | 9 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2008 | 162 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2006 | 86 | 0.020 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2006 | 15 | 0.020 |
Why?
|
| Education, Medical | 1 | 2005 | 15 | 0.020 |
Why?
|
| Patient Care | 1 | 2004 | 36 | 0.010 |
Why?
|
| Rural Population | 1 | 2004 | 52 | 0.010 |
Why?
|
| Spironolactone | 1 | 2003 | 7 | 0.010 |
Why?
|
| Mineralocorticoid Receptor Antagonists | 1 | 2003 | 10 | 0.010 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2003 | 21 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2003 | 43 | 0.010 |
Why?
|
| Education, Medical, Graduate | 1 | 2003 | 20 | 0.010 |
Why?
|
| Emergency Treatment | 1 | 2002 | 8 | 0.010 |
Why?
|
| Seroepidemiologic Studies | 1 | 2002 | 20 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2002 | 51 | 0.010 |
Why?
|
| Community Health Nursing | 1 | 2002 | 1 | 0.010 |
Why?
|
| Poverty Areas | 1 | 2002 | 22 | 0.010 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2003 | 90 | 0.010 |
Why?
|
| Risk Adjustment | 1 | 2002 | 32 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2002 | 120 | 0.010 |
Why?
|